Douglas Thomson

Douglas Thomson is a seasoned executive with expertise in infectious disease R&D and commercialization. He currently serves as Co-founder and Chief Executive Officer at Pneumagen. This follows tenures as CEO of SingVax, based in Singapore, and as Business Development Director at Microscience Ltd. Mr. Thomson sits on the board of Omideon, a St. Andrews-based biotech company focused on the development of novel treatments for cancer. He is a non-executive director of EnteroBiotix, a microbiome therapeutics platform and product company and a Venture Partner with the KAMRA fund, which is focused on infectious disease.